• A visiting doctor performs 3 successful robotic surgeries at Al Qassimi Hospital
  • The ministry’s precedence in terms of adopting robotic surgeries
  • Visiting Doctors Programme fulfills its objectives

Dubai: The Ministry of Health and Prevention (MoHAP) has unveiled the launching of Robotic Surgeries Programme in Gynaecology and Obstetrics.

This achievement, which is considered the first-of-its-kind across the UAE, comes within the context of MoHAP’s integrated programme to consolidate the success of robotic surgeries in the country, and also as part of the ministry’s keenness on promoting the culture of innovation and fostering the use of Artificial Intelligence (AI) as a scientific approach in health services. MoHAP is planning to provide this service “Robotic Surgeries” regularly and constantly.

Robotic Surgeries: The Positive Outcomes

Dr. Zaki Al-Muzaki, head of chest and vascular surgery and robot surgery program at the Ministry of Health and Prevention, said that the launching of Robotic Surgeries Programme in Gynaecology and Obstetrics comes in the wake of the successful use of the robot in heart surgeries, noting the fast-growing use of robots and AI in modern medicine.

“MoHAP took the precedence in bringing the latest robots due to its capability of accessing the most difficult parts in the human body, besides its high accuracy because of the robotic arm firmness during the surgery. Additionally, the use of robots reduces doctors’ stress and also reduces patients’ pain following the surgery. Currently, robots are used in heart, sleeve gastrectomy, and urology surgeries,” added Dr.  Zaki

He revealed the success of 3 robotic surgeries with shorter operative time (around one hour for each surgery), in addition to patients’ speed recovery. They were in good condition and left the hospital without any complications and very little pain. Surgeries were characterized by using small cuts instead of the traditional large-sized and high-risk cuts, that require longer hospitalization time.

In the same context, Al Qassimi Hospital, Sharjah, hosted Dr. Labib Riachi, Obstetrician-gynaecologist and specialized in robotic surgery, member of American Board of Female Pelvic Medicine and Reconstructive Surgery, during the period from 17 to 19 February.

Dr. Riachi provided medical consultations for Obstetrics and Gynaecology patients and performed surgeries for chronic cases by using (da Vinci Robot). On the sidelines of the visit, Dr. Riachi gave a lecture on the robot’s role and its effectiveness in Obstetrics and Gynaecology, in addition to its positive outcome with regards to the treatment progress. Diverse cases have been discussed, such as benign cysts, tumors, and other cases.

Dr. Riachi’s visit falls under the Visiting Doctors Programme, which is organized by MoHAP with a view to enriching its staff’s experience and making use of the international expertise.

Dr. Sultan Ahmed Sharif, Director of the MoHAP’s Visiting Doctors Office, said that the Visiting Doctors Programme aims to promote treatment methods and to keep pace with the latest developments in the global health arena, besides extending cooperation channels and sharing experience among MoHAP’s doctors and the visiting doctors.

He also pointed out that the programme focuses on strengthening the scientific communication with the most prestigious global centres, so as to upgrade healthcare and therapeutic levels, in accordance with the highest-quality international standards, in line with the National Health Strategy and the UAE Vision 2021, which aims to provide world-class medical services.   

© Press Release 2019

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.